Biosensors are an analytical device that convert a biological response into an electrical signal. This report involves the study of different applications in which these biosensors are mainly used such as point-of-care, home diagnostics, research labs, biodefense, environmental monitoring, and food & beverages industry. In addition, it covers technologies including electrochemical biosensors, optical biosensors, piezoelectric biosensors, thermal biosensors, nanomechanical biosensors, and nanomechanical biosensors. Moreover, this report provides a detailed analysis of the current market trends and future estimations from 2019 to 2026.

Petroleum exploration is primarily concerned with the geological interpretation of geophysical data. Geophysical data is usually gathered through geophysical methods by petroleum geologists to identify the presence of an active hydrocarbon system in various geologies. There are three main geophysical methods used in petroleum exploration: magnetic surveying, gravity surveying, and seismic surveying. Seismic survey is a vital part of exploring oil and gas. This method is based on the analysis of elastic waves generated in the Earth by artificial means. The elastic waves produced during sudden disturbance is called a seismic wave. A seismic source, such as underground dynamite or air gun, is used to generate seismic waves, sensed by receivers deployed, along with a preset geometry (called receiver array or geophones), and then recorded by a digital device called seismograph and the record obtained is known as seismogram. Based on a common propagation mechanism used in a seismic survey, seismic waves are grouped primarily into direct, reflected, refracted, and surface waves.

Sound navigation and ranging or Sonar is used for exploring, detecting, and mapping the ocean, since, sound waves travel farther in the water and experience less attenuation than radio frequency and optical signals. Sonar systems record the sound waves using hydrophones and process the signals to detect, locate, and classify different objects. The sonar system can be classified into two types - active and passive. Active sonar systems emit acoustic signals into the water and if an object is in the path of the sound pulse, the reflected signal returns an “echo” to the sonar transducer. Based on the time between the emission and reception of the acoustic pulse, the range and orientation of the object can be determined. Passive sonar systems are used to detect noise from marine objects without emitting its signal. This system is highly advantageous for military vessels that do not want to reveal its location to enemy military vessels in the water. Multiple passive sonar devices are used for the triangulation of a sound source. Sonar systems are widely being used for hydrography, oil exploration, fishing, and nautical charting activities.

The sterilization equipment market is largely driven by increasing risks of cross-transmission in hospitals and other healthcare settings. According to a study conducted by Philip L. Russo et al., published in the Antimicrobial Resistance & Infection Control Journal, 2019, in Australia, the prevalence of patients with a hospital acquired infection (HAI) was 9.9%. The most common HAIs’ were surgical site infection, pneumonia, and urinary tract infection. The incidence is expected to be more in hospitals in developing and underdeveloped countries due to the lack of precautionary facilities. Other factors driving the growth of the market are the increasing number of surgical procedures, globally, primarily due to increasing number of chronic diseases and injuries. Additionally, due to the growth in the pharmaceutical industry, around the world, people are aware of sterilization equipment. These factors have also boosted the market growth. However, high stringent regulatory guidelines for market approval of devices and use of potentially harmful chemicals in these equipment have been restraining the market growth.

The global whole genome and exome sequencing market witnessed eight significant acquisitions during January 2017 to February 2020. All the acquisitions were aimed at the expansion of the product portfolio by acquiring sequencing-based portfolios with promising growth potential. Also, these acquisitions were intended to strengthen the existing product portfolio for improving accuracy and sensitivity of whole genome and exome sequencing methods. For instance, the acquisition of NEO Oncology AG by Siemens Healthineers, Inc. was aimed at expanding the company's portfolio to cater to the NGS-based molecular diagnostic market for cancer diagnosis and analysis. Further, Agilent Technologies, Inc. company acquired Population genetics for the development of IP portfolio which is aimed at improving accuracy and sensitivity of NGS detection.

Over the past few decades, viral and non-viral vectors are increasingly being used for the development of novel therapies. These vectors are helpful in achieving in-vivo delivery of gene to a targeted cell or tissue. Viral vectors such as adeno-associated virus, lentivirus, and retrovirus are some of the commonly used vectors utilized in several clinical and preclinical trials evaluating gene and cell therapy products as well as vaccines. For example, recombinant retroviruses are mostly used for the development of various gene therapies, targeting a number of genetic diseases, such as Marfan syndrome, hemochromatosis, Huntington’s disease, and sickle cell anemia. Retroviruses are mainly used to increase the expression of the genes and for easy chromosomal integration.

The global tumor genomics market represents the market scenario of the genomic technologies used for detection of various kinds of cancer across the world, taking into considerations of key established companies and their product contributions. The following chapter provides in-depth study of the factors affecting the growth of the tumor genomics market among different geographical regions. Market drivers, challenges or restraints are some of the factors that influence the market growth either by advancing or retarding the growth. Market opportunities are some of the factors for future growth of the market. Apart from these market dynamics, the following sections also describe the regulatory scenario of the global tumor genomics market that includes the approval and launches of various genomic products used for the identification of disease and analyzing the diseases conditions. Furthermore, this section also provides an overview of the competitive landscape that shows the key companies market share and their product offerings in the tumor genomics market. Following these sections, the report also covers the different market segmentation such as products, techniques, applications, end users, and cancer types. In addition, the region chapter enumerates the market scenario of different regions as well as different countries, their market dynamics and market size for each of the regions and countries as well. Furthermore, the company profiling section provides an overview of the key companies, SWOT, financials (for public companies), and their products offerings pertaining to global tumor genomics market